REPL insider trading
Open-market stock trades by Replimune (REPL) executives and directors: who bought or sold, how many shares, at what price and when.
REPL insider trades
| Date | Insider | Role | Trade | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Hill Emily Luisa | Chief Financial Officer | Sell | 9,256 | $14.28 | $132.18K |
| Aug 10, 2026 | Patel Sushil | Chief Executive Officer | Sell | 39,341 | $12.97 | $510.25K |
| Aug 10, 2026 | Hill Emily Luisa | Chief Financial Officer | Sell | 11,448 | $12.97 | $148.48K |
| Aug 10, 2026 | Xynos Konstantinos | Chief Medical Officer | Sell | 11,447 | $12.97 | $148.47K |
| Aug 10, 2026 | Schwendenman Andrew | Chief Accounting Officer | Sell | 7,632 | $12.97 | $98.99K |
| Aug 11, 2026 | BAKER BROS. ADVISORS LP | Buy | 2,609,946 | $0.00 | $260.99 | |
| Aug 11, 2026 | BAKER BROS. ADVISORS LP | Buy | 126,394 | $0.00 | $12.64 | |
| Jun 1, 2026 | Sarchi Christopher | Chief Commercial Officer | Sell | 12,000 | $9.24 | $110.88K |
| May 18, 2026 | Xynos Konstantinos | Chief Medical Officer | Sell | 14,023 | $5.08 | $71.24K |
| May 18, 2026 | Schwendenman Andrew | Chief Accounting Officer | Sell | 7,894 | $5.08 | $40.10K |
| May 18, 2026 | Sarchi Christopher | Chief Commercial Officer | Sell | 8,626 | $5.08 | $43.82K |
| May 18, 2026 | Astley-Sparke Philip | director | Sell | 17,657 | $5.08 | $89.70K |
| May 18, 2026 | Patel Sushil | Chief Executive Officer | Sell | 37,324 | $5.08 | $189.61K |
| May 18, 2026 | Hill Emily Luisa | Chief Financial Officer | Sell | 7,812 | $5.08 | $39.68K |
| Apr 2, 2026 | Sarchi Christopher | Chief Commercial Officer | Sell | 6,500 | $8.01 | $52.06K |
| Dec 9, 2025 | Dhingra Kapil | director | Sell | 3,169 | $10.40 | $32.96K |
| Dec 2, 2025 | Patel Sushil | Chief Executive Officer | Sell | 10,000 | $11.13 | $111.30K |
| Nov 17, 2025 | Sarchi Christopher | Chief Commercial Officer | Sell | 5,208 | $9.10 | $47.39K |
| Nov 17, 2025 | Xynos Konstantinos | Chief Medical Officer | Sell | 7,248 | $9.10 | $65.96K |
| Aug 15, 2025 | Hill Emily Luisa | Chief Financial Officer | Sell | 9,154 | $5.37 | $49.16K |
| May 20, 2025 | Astley-Sparke Philip | director | Sell | 32,279 | $8.06 | $260.17K |
| May 20, 2025 | Xynos Konstantinos | Chief Medical Officer | Sell | 7,952 | $8.06 | $64.09K |
| May 20, 2025 | Schwendenman Andrew | Chief Accounting Officer | Sell | 3,287 | $8.05 | $26.46K |
| May 20, 2025 | Patel Sushil | Chief Executive Officer | Sell | 25,105 | $8.06 | $202.35K |
| May 20, 2025 | Hill Emily Luisa | Chief Financial Officer | Sell | 2,535 | $8.05 | $20.41K |
| May 20, 2025 | Sarchi Christopher | Chief Commercial Officer | Sell | 3,749 | $8.05 | $30.18K |
| Dec 16, 2024 | Patel Sushil | Chief Executive Officer | Sell | 10,000 | $12.42 | $124.20K |
| Nov 18, 2024 | Xynos Konstantinos | Chief Medical Officer | Sell | 7,246 | $10.78 | $78.11K |
| Nov 18, 2024 | Sarchi Christopher | Chief Commercial Officer | Sell | 5,207 | $10.78 | $56.13K |
| Aug 16, 2024 | Hill Emily Luisa | Chief Financial Officer | Sell | 8,938 | $10.18 | $90.99K |
| Jun 7, 2024 | Xynos Konstantinos | Chief Medical Officer | Sell | 15,881 | $7.50 | $119.11K |
| May 16, 2024 | Sarchi Christopher | Chief Commercial Officer | Sell | 2,218 | $6.47 | $14.35K |
| May 16, 2024 | Schwendenman Andrew | Chief Accounting Officer | Sell | 2,298 | $6.47 | $14.87K |
| May 16, 2024 | Love Colin | Chief Operating Officer | Sell | 17,615 | $6.47 | $113.97K |
| May 16, 2024 | Astley-Sparke Philip | Executive Chairman | Sell | 37,928 | $6.47 | $245.39K |
| May 16, 2024 | Coffin Robert | director | Sell | 11,464 | $6.47 | $74.17K |
| May 16, 2024 | Patel Sushil | Chief Executive Officer | Sell | 20,194 | $6.47 | $130.66K |
| May 16, 2024 | Xynos Konstantinos | Chief Medical Officer | Sell | 6,367 | $6.47 | $41.19K |
- REPL insiders bought $273.63 and sold $3.69M in open-market trades over their last 38 filings.
Updated 2026-11-03 00:01 UTC